BSE filing, NSE: AVADHSUGAR. Summary written from the filing by ALFA Finder's alert engine.
Avadh Sugar & Energy Ltd: key numbers
- Share price
- ₹859.75
- Market cap
- ₹1,721 Cr
- Revenue (annual)
- ₹2,694 Cr
- Net profit (annual)
- ₹57.31 Cr
- P/E (TTM)
- 26.1×Sector 27.1×
- Promoter holding
- 60.39%+0.00% QoQ
- FII holding
- 2.04%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Avadh Sugar & Energy Ltd
All →Avadh Sugar & Energy Other Announcement
Avadh Sugar & Energy Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by SEBI (LODR) regulations.
Avadh Sugar & Energy Investor Presentation: Key Takeaways
Avadh Sugar reported Q1FY27 revenue growth of 9% YoY and EBITDA growth of 34%, with PAT turning positive compared to a loss in Q1FY26. Strategy focuses on distillery integration and value-added sugar.
Avadh Sugar & Energy Q1 FY27 Results: Turns Profitable, Net Profit ₹0.2 Cr
Avadh Sugar & Energy Ltd reported revenue from operations of ₹779.3 Cr (+8.7% YoY) and net profit of ₹0.2 Cr for Q1 FY27.
- Key figure
- Net profit ₹0.2 Cr
Avadh Sugar & Energy Annual General Meeting
Avadh Sugar & Energy Limited concluded its 12th Annual General Meeting on July 28, 2026. Shareholders approved all resolutions, including a 100% dividend of Rs. 10 per share.
Avadh Sugar & Energy Board Meeting Date
Avadh Sugar & Energy Limited scheduled a board meeting on August 3, 2026, to consider and approve the unaudited financial results for the quarter ending June 30, 2026.
Avadh Sugar & Energy Business Update
Avadh Sugar filed its BRSR for FY 2025-26, detailing operations and employee data. The report covers sustainability disclosures and business activities as per SEBI norms.
Other results update announcements
All →Aatmaj Healthcare Results Update
Aatmaj Healthcare reported H1 FY27 revenue of Rs. 16.96 crore and EBITDA of Rs. 2.04 crore. The company targets 80% revenue growth for FY27.
RPG Life Sciences Results Update
RPG Life Sciences reported Q2 FY27 revenue of ₹211.6 crore, growing 16.5%, and adjusted EBITDA of ₹50.1 crore. The API business integration continues to progress.
Praruh Technologies Results Update
Praruh Technologies reported strong H1 FY27 growth, with revenue rising 378% YoY to ₹84.06 Crore and PAT increasing 733% to ₹8.18 Crore.
CARE Ratings Results Update
CARE Ratings reported strong Q2 and H1 FY27 operating income and profit growth. The board also declared an interim dividend of Rs 10 per share.
EPACK Durables Results Update
EPACK Durable reported record first-half revenue and strong Q2 FY27 growth. The board also approved exiting its EPAVO joint venture stake.
3i Infotech Results Update
3i Infotech reported Q2FY27 revenue of Rs.182.0 crore, up 4.1% year-on-year. Quarterly PAT stood at Rs.6.7 crore and 25 new client wins were added.